300030 Improve Medical Instruments
- 6.48
- -0.51-7.30%
About Improve Medical Instruments Company
The company was founded in 1996. It is a high-tech enterprise that has been engaged in mutation control research for 27 years before specimen analysis. It has been deeply involved in becoming a leader in the domestic venous specimen collection field and is at the top of the global industry rankings. In 2009, Yangpu Medical entered the Shenzhen Stock Exchange GEM. The company's main business is testing services, smart medical care, precision medicine, etc. The company's main products include: vacuum blood collection systems, liquid biopsy tubes, fully automatic blood collection and capping machines, intelligent blood collection and sorting systems, customized software systems, thromboelastography instruments and reagents, rare cell sorters (AF-RCFS series) and reagents, rare cell sorting chips & filters (rare cell capture microfluidic control chips), rare cell isolation and multi-dimensional detection platforms, tumor testing, pathogen detection, genetic disease testing, drug sensitivity testing, etc. Company honors: Guangdong High-tech Enterprise, National Intellectual Property Advantage Enterprise, Guangdong Import and Export Famous Brand Enterprise, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- guanhua deng
- Chairman, Directors, President, Chairman of the Strategy Committee, Nomination Committee Members, Member of the Remuneration and Assessment Committee
- 1.29M
- wei yu
- Directors, Board Secretary, Member of the Strategy Committee
- 560.40K
- ke tian
- Directors, Deputy General Manager, Member of the Strategy Committee
- 562.60K
- yanli tian
- Directors, Member of the Strategy Committee, Audit Committee Members
- 382.90K
- guangcheng jiang
- Directors, Deputy General Manager, Member of the Strategy Committee
- 563.90K
- xiangxiang deng
- Directors, Member of the Strategy Committee
- --
- huanliang liu
- Independent Directors, Member of the Remuneration and Assessment Committee, Member of the Strategy Committee, Nomination Committee Members
- 52.80K
- ying liu
- Independent Directors, Member of the Strategy Committee, Chairman of the Nomination Committee, Audit Committee Member
- 52.80K
- hua bai
- Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee, Member of the Strategy Committee
- 100.00K
- xuhua zhuang
- Securities Affairs Representative
- --
- guangzhi xu
- Chairman of the Supervisory Board, Auditors
- 591.30K
- xiaojian li
- Auditors
- 349.30K
- lixin xu
- Deputy General Manager
- 483.60K
- hongyu yan
- Deputy General Manager, Chief Financial Officer
- 491.50K
- xiaochen huang
- Employee Supervisors
- 215.60K
Analysis
Price Target
No Data
No Data